Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
130
NMPA:130
Drug Approvals
Polyethylene Glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate and Ascorbic Acid Powder
- Product Name
- 复方聚乙二醇(3350)电解质维C散
- Approval Number
- 国药准字H20254017
- Approval Date
- Apr 30, 2025
NMPA
Ziprasidone Mesilate for Injection
- Product Name
- 注射用甲磺酸齐拉西酮
- Approval Number
- 国药准字H20249753
- Approval Date
- Dec 17, 2024
NMPA
Dapagliflozin and Metformin hydrochloride Sustained-release Tablets（III）
- Product Name
- 达格列净二甲双胍缓释片(Ⅲ)
- Approval Number
- 国药准字H20249467
- Approval Date
- Dec 1, 2024
NMPA
Dapagliflozin and Metformin hydrochloride Sustained-release Tablets（I）
- Product Name
- 达格列净二甲双胍缓释片(Ⅰ)
- Approval Number
- 国药准字H20249466
- Approval Date
- Dec 1, 2024
NMPA
Indocyanine Green for Injection
- Product Name
- 注射用吲哚菁绿
- Approval Number
- 国药准字H20249047
- Approval Date
- Oct 16, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found